Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $177.37 USD
Change Today +0.24 / 0.14%
Volume 280.2K
JAZZ On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Bruce C. Cozadd

Co-Founder, Executive Chairman and Chief Executive Officer, Jazz Pharmaceuticals Public Limited Company
AgeTotal Calculated CompensationThis person is connected to 102 board members in 4 different organizations across 5 different industries.

See Board Relationships
51$11,555,501
As of Fiscal Year 2014

Background*

Mr. Bruce C. Cozadd co-founded Jazz Pharmaceuticals Public Limited Company (also known as Jazzpharmaceuticals, Inc.) in 2003 and has been Executive Chairman and Chief Executive Officer since January 2012. Mr. Cozadd serves as the Chairman and Chief Executive Officer at Azur Pharma Limited. He served in various executive management positions with ALZA Corporation from 1991 to 2001, including Vice President of Corporate Planning and Analysis. He served as Executive Vice ...

Read Full Background

Corporate Headquarters*

Connaught House
Dublin, Co. Dublin 4

Ireland

Phone: 353 1 634 7800
Fax: 353 1 634 7850

Board Members Memberships*

Chairman, Chief Executive Officer, Chairman of Jazz Pharmaceuticals, Inc. and Chief Executive Officer of Jazz Pharmaceuticals, Inc.
2000-N/A
Director and Chairman of Audit Committee
2001-Present
Independent Director, Chairman of Audit Committee and Member of Compensation Committee
2005-Present
Director and Member of Compensation Committee
2012-Present
Co-Founder, Executive Chairman and Chief Executive Officer

Education*

BA
Yale University
MBA
Stanford Graduate School of Business

Other Affiliations*

Annual Compensation*

Salary$830,000
Total Annual Compensation$830,000

Stock Options*

Restricted Stock Awards$5,498,457
All Other Compensation$11,692
Exercisable Options185,144
Exercisable Options Value$21,458,195
Unexercisable Options219,647
Unexercisable Options Value$17,096,484
Total Value of Options$38,554,679
Total Number of Options404,791

Total Compensation*

Total Annual Cash Compensation$1,862,592
Total Short Term Compensation$830,000
Other Long Term Compensation$5,510,149
Total Calculated Compensation$11,555,501
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JAZZ:US $177.37 USD +0.24

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$854.7K
Jean-Jacques Bienaime MBAChairman and Chief Executive Officer
BioMarin Pharmaceutical Inc.
$916.0K
Rajat Rai Chief Executive Officer
Akorn, Inc.
$1.1M
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
$2.9M
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
$552.5K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JAZZ PHARMACEUTICALS PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.